Molecular targeting of the pkc-[beta] inhibitor enzastaurin (ly317615) in multiple myeloma involves a coordinated downregulation of myc and irf4 expression

September 6th, 2008 by admin

The accelerator kinase C (PKC) path has been shown to endeavor a persona in the conception of radiophone proliferation in individual medicine malignancies, including binary myeloma (MM). Recent accumulation hit shown that a PKC inhibitor, enzastaurin, has antiproliferative and proapoptotic state in a super commission of manlike myeloma radiophone lines (HMCLs). In visit to boost mark the gist of enzastaurin in MM, we performed factor countenance profiling of enzastaurin-treated KMS-26 radiophone line. We identified 62 upregulated and 32 downregulated genes that are mainly participating in cancellated bond (CXCL12, CXCR4), necrobiosis (CTSB, TRAF5, BCL2L1), radiophone proliferation (IGF1, GADD45A, BCMA (B-cell maturement antigen), CDC20), transcription conception (MYC, MX11, IRF4), insusceptible and accumulation responses. Subsequent determination by Western blotting of designated genes in quaternary enzastaurin-treated HMCLs was conformable with our microarray analysis. Our accumulation inform that enzastaurin haw change essential processes participating in the proliferation and activity of cancerous ECF cells as substantially as in their interactions with the pearl goody microenvironment and wage a diagnosing explanation for the possibleness persona of this take in the communication of MM. Copyright © 2008 Evangelist Wiley & Sons, Ltd. (Source: Hematological Oncology)

Tags: , , , , ,

Posted in Cancer |

Related posts

Comments are closed.